Venture Partners L P Sofinnova VII's Net Worth
$144 Million
Who is Venture Partners L P Sofinnova VII?
Venture Partners L P Sofinnova VII has an estimated net worth of $144 Million. This is based on reported shares across multiple companies, which include AMARIN CORP PLC\UK, Trius Therapeutics Inc, HYPERION THERAPEUTICS INC, AERIE PHARMACEUTICALS INC, Durata Therapeutics, Inc., and ANESIVA, INC..
SEC CIK
Venture Partners L P Sofinnova VII's CIK is 0001380734
Past Insider Trading and Trends
2010 was Venture Partners L P Sofinnova VII's most active year for acquiring shares with 6 total transactions. Venture Partners L P Sofinnova VII's most active month to acquire stocks was the month of July. 2011 was Venture Partners L P Sofinnova VII's most active year for disposing of shares, totalling 7 transactions. Venture Partners L P Sofinnova VII's most active month to dispose stocks was the month of February. 2010 saw Venture Partners L P Sofinnova VII paying a total of $16,126,140.20 for 7,231,144 shares, this is the most they've acquired in one year. In 2015 Venture Partners L P Sofinnova VII cashed out on 1,939,474 shares for a total of $89,215,804.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMARIN CORP PLC\UK (AMRN) Snapshot price: $0.6094
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.75% | -424.90K |
$7.25 | -$3,080,609.98 | 8.51M |
Mar 29
| |||
Form 4
| -6.05% | -575.10K |
$7.55 | -$4,341,332.61 | 8.94M |
Mar 24 - Mar 25
| |||
Form 4
| -17.37% | -2.00M |
$7.50 | -$15,000,000.00 | 9.51M |
Mar 11
| |||
Form 4
| -5.24% | -637.00K |
$7.26 | -$4,622,857.88 | 11.51M |
Mar 9 - Mar 10
| |||
Form 4
| -2.90% | -363.00K |
$8.13 | -$2,952,787.20 | 12.15M |
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
HYPERION THERAPEUTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.94M |
$46.00 | -$89,215,804.00 |
0
|
May 7
| |||
Form 4
| -17.72% | -417.75K |
$27.70 | -$11,571,591.90 | 1.94M |
Jun 4
| |||
Form 4
| -20.02% | -590.00K |
$30.02 | -$709,222.50 | 2.36M |
Scheduled
|
Mar 3 - Mar 4
| ||
Form 4
| +74,816.65% | 2.94M |
$10.00 |
—
| 2.95M |
Jul 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AERIE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.15% | -1.01M |
$24.91 | -$24,208,330.17 | 1.57M |
Jul 9 - Jul 10
| |||
Form 4
| -6.94% | -191.98K |
—
|
—
| 2.57M |
Jun 2
| |||
Form 4
| -10.48% | -323.93K |
$16.00 | -$5,182,912.00 | 2.77M |
May 22
| |||
Form 4
|
∞
| 3.09M |
$6.49 |
—
| 3.09M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Durata Therapeutics, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +134.95% | 2.27M |
$9.00 | $5,294,124.00 | 3.95M |
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Trius Therapeutics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -96.00% | -3.47M |
—
|
—
| 144.65K |
Scheduled
|
Jan 12
| ||
Form 4/A
|
∞
| 3.62M |
$4.68 |
—
| 3.62M |
Aug 6
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 3.62M |
$4.68 |
—
| 3.62M |
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |